Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Utreloxastat is a compound used to study diseases including alpha-synucleinopathies, tauopathies, ALS, traumatic brain injury, and ischemic-reperfusion related injuries.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 108.00 | |
5 mg | In stock | $ 272.00 | |
10 mg | In stock | $ 396.00 | |
25 mg | In stock | $ 662.00 | |
50 mg | In stock | $ 997.00 | |
100 mg | In stock | $ 1,730.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 248.00 |
Description | Utreloxastat is a compound used to study diseases including alpha-synucleinopathies, tauopathies, ALS, traumatic brain injury, and ischemic-reperfusion related injuries. |
Molecular Weight | 276.41 |
Formula | C18H28O2 |
CAS No. | 1213269-96-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Utreloxastat 1213269-96-5 inhibitor inhibit